title: Re: One year perspective on COURAGE.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Sedlis
authors.forename: William E
authors.initials: WE
authors.lastname: Boden
authors.forename: William S
authors.initials: WS
authors.lastname: Weintraub
authors.forename: David S
authors.initials: DS
authors.lastname: Maron
authors.forename: Robert A
authors.initials: RA
authors.lastname: O'Rourke
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Berman
authors.forename: G B John
authors.initials: GB
authors.lastname: Mancini
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents